Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | SLC6A6 | P31641 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | BLM | P54132 | 1/20 | 0.39 |
| ▸ | APP | P05067 | 1/20 | 0.36 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.36 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.36 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.36 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.33 |
| ▸ | PDE4A | P27815 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | ENPEP | Q07075 | 4/20 | 0.33 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1920398 | 0.76 | — | — | |
| SCHEMBL28980311 | 0.76 | PTGS1 (0.36) | LMNASLC6A6CYP2C19BLMAPP | |
| SCHEMBL28137092 | 0.76 | PTGS1 (0.36) | LMNASLC6A6CYP2C19BLMAPP | |
| SCHEMBL766601 | 0.74 | PTGS1 (0.35) | LMNASLC6A6CYP2C19BLMAPP | |
| SCHEMBL766602 | 0.74 | PTGS1 (0.35) | LMNASLC6A6CYP2C19BLMAPP | |
| SCHEMBL20528290 | 0.74 | PMP22 (0.38) | LMNASLC6A6CYP2C19BLMAPP | |
| SCHEMBL356494 | 0.73 | — | — | |
| SCHEMBL21623887 | 0.73 | — | — | |
| SCHEMBL11489923 | 0.73 | PTGS1 (0.33) | LMNASLC6A6CYP2C19BLMAPP | |
| SCHEMBL15770527 | 0.73 | PTGS1 (0.33) | LMNASLC6A6CYP2C19BLMAPP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2326619-A2 | METHIONINE ANALOGS AND METHODS OF USING SAME | Bioxiness Pharmaceuticals, Inc. (US) | 2011-06-01 | — | — | EP | disclosed |
| WO-2010014943-A2 | METHIONINE ANALOGS AND METHODS OF USING SAME | BIOXINESS PHARMACEUTICS, INC. (US) | 2010-02-04 | — | — | WO | disclosed |